Tomai Radu Andrei, Iluta Sabina, Tigu Adrian Bogdan, Nistor Madalina, Bancos Anamaria, Cenariu Diana, Jitaru Ciprian, Patcas Sergiu, Dima Delia, Kegyes David, Buruiana Sanda, Zdrenghea Mihnea, Tanase Alina Daniela, Tomuleasa Ciprian, Micu Romeo
Department of Haematology, Ion Chiricuta Institute of Oncology, 400015 Cluj-Napoca, Romania.
Department of Translational Medicine, Institute of Medical Research and Life Sciences-MEDFUTURE, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Diagnostics (Basel). 2024 Sep 20;14(18):2084. doi: 10.3390/diagnostics14182084.
: Spontaneous remission of cancer is a rare and poorly understood phenomenon characterized by complete or partial remission of a malignancy in the absence of or with inadequate treatment. The underlying mechanism for such occurrences is poorly understood, however, immune mechanisms seem to play an important role in such cases. In recent years increasingly more data have become available in favor of the clinical benefit of low levels of chimerism in hematologic malignancies. One such instance of naturally occurring low-level chimerism is feto-maternal microchimerism which has been shown to influence cancer progression and, in some instances, to be a protective factor against malignancy. : We report a case of a young female patient with aggressive primary mediastinal large B cell lymphoma refractory to two lines of chemo-immunotherapy achieving sustained complete metabolic remission of tumor while pregnant with twins. : A focus on feto-maternal microchimerism during and after pregnancy revealed transient levels of feto-maternal microchimerism in the peripheral blood of the patient as measured by quantifying the Y-chromosome-linked SRY gene. : Microchimerism presents significant potential for enhancing our comprehension of disease mechanisms, uncovering novel therapeutic targets, and refining diagnostic and treatment approaches, especially concerning cancer.
癌症的自发缓解是一种罕见且了解甚少的现象,其特征是在没有治疗或治疗不充分的情况下,恶性肿瘤完全或部分缓解。虽然这种情况发生的潜在机制尚不清楚,但免疫机制似乎在这些病例中起着重要作用。近年来,越来越多的数据表明血液系统恶性肿瘤中低水平嵌合体具有临床益处。自然发生的低水平嵌合体的一个例子是胎儿-母体微嵌合体,它已被证明会影响癌症进展,在某些情况下,还是对抗恶性肿瘤的保护因素。
我们报告了一例年轻女性患者,患有侵袭性原发性纵隔大B细胞淋巴瘤,对两线化疗免疫治疗均耐药,在怀有双胞胎期间肿瘤实现了持续完全代谢缓解。
对孕期及产后胎儿-母体微嵌合体的关注发现,通过定量Y染色体连锁的SRY基因测量,患者外周血中胎儿-母体微嵌合体水平呈短暂性。
微嵌合体在增强我们对疾病机制的理解、发现新的治疗靶点以及完善诊断和治疗方法方面具有巨大潜力,尤其是在癌症方面。